tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LEXX Stock Latest News

Lexaria’s DehydraTECH-Semaglutide Cuts GLP-1 Side Effects in Phase 1b Trial and Extends Cash Runway Into 2026
Company AnnouncementsLexaria’s DehydraTECH-Semaglutide Cuts GLP-1 Side Effects in Phase 1b Trial and Extends Cash Runway Into 2026
3d ago
LEXX
Lexaria Bioscience achieves primary endpoint in Phase 1b study GLP-1-H24-4
PremiumThe Fly
Lexaria Bioscience achieves primary endpoint in Phase 1b study GLP-1-H24-4
3d ago
LEXX
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D
PremiumCompany Announcements
Lexaria Bioscience Secures $3.5 Million in Direct Offering to Boost R&D
11d ago
LEXX
Lexaria Bioscience prices 2.66M share at the market offering at $1.315
PremiumThe Fly
Lexaria Bioscience prices 2.66M share at the market offering at $1.315
11d ago
LEXX
Lexaria Extends Agreement to Advance Drug Delivery Technology Evaluation
PremiumCompany Announcements
Lexaria Extends Agreement to Advance Drug Delivery Technology Evaluation
1M ago
LEXX
Lexaria Bioscience extends material transfer agreement with pharma company
PremiumThe FlyLexaria Bioscience extends material transfer agreement with pharma company
1M ago
LEXX
Lexaria Bioscience files to sell 2.76M shares of common stock for holders
Premium
The Fly
Lexaria Bioscience files to sell 2.76M shares of common stock for holders
2M ago
LEXX
Lexaria Bioscience Expands Strategic Outreach and Secures New Patents
Premium
Company Announcements
Lexaria Bioscience Expands Strategic Outreach and Secures New Patents
3M ago
LEXX
Lexaria Bioscience engages advisory firm to identify new business opportunities
PremiumThe Fly
Lexaria Bioscience engages advisory firm to identify new business opportunities
3M ago
LEXX
Lexaria Bioscience Secures $4 Million for R&D Expansion
PremiumCompany Announcements
Lexaria Bioscience Secures $4 Million for R&D Expansion
3M ago
LEXX
Lexaria Bioscience announces $4M registered direct offering priced ATM
PremiumThe Fly
Lexaria Bioscience announces $4M registered direct offering priced ATM
3M ago
LEXX
Lexaria Bioscience prices 2.7M shares at $1.50 in registered direct offering
PremiumThe Fly
Lexaria Bioscience prices 2.7M shares at $1.50 in registered direct offering
3M ago
LEXX
Lexaria Bioscience Ends Capital on Demand Agreement
PremiumCompany AnnouncementsLexaria Bioscience Ends Capital on Demand Agreement
3M ago
8K
LEXX
Lexaria Bioscience’s DehydraTECH Boosts Semaglutide Brain Delivery
Premium
Company Announcements
Lexaria Bioscience’s DehydraTECH Boosts Semaglutide Brain Delivery
3M ago
LEXX
Lexaria Bioscience to Present at H.C. Wainwright Global Investment Conference
Premium
Company Announcements
Lexaria Bioscience to Present at H.C. Wainwright Global Investment Conference
4M ago
LEXX
Lexaria Bioscience Completes Key Phase 1b Study Milestone
PremiumCompany Announcements
Lexaria Bioscience Completes Key Phase 1b Study Milestone
4M ago
LEXX
Lexaria Bioscience study achieves last patient last visit milestone
PremiumThe Fly
Lexaria Bioscience study achieves last patient last visit milestone
4M ago
LEXX
Lexaria Bioscience announces last patient, last visit in Phase 1b GLP-1 study
PremiumThe Fly
Lexaria Bioscience announces last patient, last visit in Phase 1b GLP-1 study
4M ago
LEXX
Lexaria Bioscience Targets GLP-1 Market with DehydraTECH Innovation
PremiumCompany Announcements
Lexaria Bioscience Targets GLP-1 Market with DehydraTECH Innovation
5M ago
LEXX
Buy Recommendation for Lexaria Bioscience Based on Improved Safety Profile of DehydraTECH-semaglutide
PremiumRatingsBuy Recommendation for Lexaria Bioscience Based on Improved Safety Profile of DehydraTECH-semaglutide
5M ago
LEXX
Lexaria Bioscience price target lowered to $4 from $5 at H.C. Wainwright
Premium
The Fly
Lexaria Bioscience price target lowered to $4 from $5 at H.C. Wainwright
5M ago
LEXX
Lexaria Bioscience Reports Promising Interim Results in GLP-1 Study
Premium
Company Announcements
Lexaria Bioscience Reports Promising Interim Results in GLP-1 Study
5M ago
LEXX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >